Return to Supplier News

Source: Precimed S.A.

Precimed S.A.
7, L’Echelette
2534 Orvin
Suisse
Tel: (++) 41.32.358.01.11
Fax: (++) 41.32.358.0100
e-mail: sales@precimed.com
http://www.precimed.com

Well-known orthopaedic instrument innovator, Precimed SA (headquartered in Orvin, Switzerland) has entered into an agreement with Praxim Medivision, a leader in image guided surgery. PRAXIM Medivision was founded in 1995 by academic researchers from the CAMI (Computer Assisted Medical Interventions) team of the University Joseph Fourier (Grenoble -France). This collaboration makes it possible to combine the accuracy of image-guided surgery with the speed of standard surgical protocol for TKR. Precimed and Praxim will further integrate this IGS know-how to support the UKI™ - a universal 8-in-1 femoral knee cutting guide developed in conjunction with the Hospital for Special Surgery, New York. The alliance between Praxim and Precimed, combined with HSS's UKI™ technology provides Precimed's customers with a pioneering solution for TKR and is adaptable for use with any total knee replacement implant. UKI is a trademark of the Hospital for Special Surgery. More information is available from Precimed (www.precimed.com).

About PRAXIM Medivision
Praxim, founded in 1995, was spun off from the University Joseph Fourrier, and the TIMC Laboratory, one of the world’s leading research laboratories in computer assisted surgery and robotics, both of Grenoble, France. Praxim has developed specialized CAS software with many leading implant manufacturers, resulting in over 27 applications and providing clinically specific CAS protocols for use on the open platform SURGETICS™ Station. Praxim has brought to market many of the field’s key innovations such as Bone Morphing®. Over one hundred of its Surgetics® Stations are being used worldwide. Praxim has obtained CE mark or FDA approval on its products through tight quality assurance processes. In 2003, Praxim acquired the Swiss based company Medivision.

For more information visit www.praxim-medivision.com.

October 2004